Skip to content

Paige Prostate 1.X

by Paige.AI, Inc.

Paige Prostate 1.X is a medical device (FDA Class II; FDA product code QPN, Software Algorithm Device To Assist Users In Digital Pathology) made by Paige.AI, Inc., granted FDA De Novo DEN200080 on 21 Sep 2021 and listed in FDA GUDID since 10 Nov 2021 (UDI-DI 00860007599118), active as of 8 Nov 2026.

Active United States. Also listed in GUDID (US).

De Novo

Valid until

No expiry

De Novo grant is not time-limited

FDA recalls

None found

in data synced 8 Nov 2026

Documents

De Novo DEN200080

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 8 Nov 2026.

Regulatory status

as of registry sync 8 Nov 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00860007599118 UDI-DI Date10 Nov 2021ListedStatusListed GUDID: in commercial distribution
United StatesFDA De NovoDENG from GUDID De Novo granted · Direct NumberDEN200080 Date21 Sep 2021DecidedStatusActive

Official records

From the FDA record

Device description
Paige Prostate is a software only device intended to assist pathologists in the detection of foci that are suspicious for cancer during the review of scanned whole slide images (WSI) from prostate needle biopsies prepared from hematoxylin & eosin (H&E) stained formalin-fixed paraffin embedded (FFPE) tissue. After initial diagnostic review of the WSI by the pathologist, if Paige Prostate detects tissue morphology suspicious for cancer, it provides coordinates (X,Y) on a single location on the image with the highest likelihood of having cancer for further review by the pathologist.
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 8 Nov 2026, as the labeller entered it.

Across registries

2 registries list this device

  • FDA De Novo DEN200080 decided 21 Sep 2021 Active
  • FDA GUDID UDI-DI 00860007599118 listed 10 Nov 2021 Listed

Timeline

2 dated events

  1. Granted FDA De Novo DEN200080
  2. Listed FDA GUDID 00860007599118

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA De Novo Active

Specification

GUDID

Trade name
Paige Prostate
Generic name
Histology/cytology/microbiology image-analysis interpretive software IVD
Model / reference
1.X
Primary DI / UDI-DI
00860007599118
De Novo Number
FDA product code
QPN
GMDN term
Histology/cytology/microbiology image-analysis interpretive software IVD
Device class
Class II
Regulation number
864.3750
GUDID distribution status
In Commercial Distribution

Other devices from Paige.AI, Inc.

Properties

  • Serial number
Other properties (14, all answered No)